EFFECT OF LISINOPRIL ON MICROALBUMINURIA
Abstract
The purpose of this study was to evaluate the effect of Lisinopril on microalbuminuria in non- insulin dependentdiabetic hypertensive patients. One hundred and twenty patients were divided into two groups. Croup-A was given
placebo of Lisinopril and Group-B was given Lisinopril in a fixed dose of 10 mg once daily for two weeks. Comparison
of microalbuminuria before and after the treatment showed a decrease in microalbuminuria level in patients treated
with Lisinopril.
References
I Philip R. How to treat hypertension in diabetic
patients? Postgraduate Med Hypertens Diabetes 1987;
(2): 213-32.
Viberti GC. 1 Hill RD. Jarret RJ and Keen 11.
Microalbuminuria as a predictor of clinical
nephropathy in insulin dependent diabetes mellitus.
Lancet 1982; 1 1430.
Crepaldi G. Carraro A. Broccoe et al. Hypertension and
noninsulin dependent diabetes. A comparison between
an angiotension converting enzyme inhibitor and a
calcium antagonist. Acta Diabetol 1995; 32(3): 203-8.
Brenner BM. Meyer TW and Hostetler TH. Dietary
protein intake and the progressive nature of kidney
disease. N. F.ng .1 Med 1982. 307: 652.
Hostetter Th. Rennke HG and Brenner BMV The case
for internal hypertension in the initiation and
progression diabetic and other glomerulopathies. Am .1
Med 1982:72 375.
Remuzzi A. Benigni A. Malanchini B et al. ACL
inhibition prevents renal failure and death in
uninephrectomized MWF/Ztn rats. Kidney Int. 1995;
(5): 1319-26.
Barkis GL, Copley JB. Vicknair N et al. Calcium
channel blockers versus other antihypertensive therapy
on progression of NIDDM associated nephropathy.
Kidney Int. 1996: 50(5): 1641-50.
Agardh CP. Garcia P.l. Charbannel B et al. Greater
reduction of urinary albumin excretion in hypertensive
type-11 diabetic patients with incipient nephropathy by
Lisinopril than by nifedipine .1 Human Hypertens
; 10(3): 185-92.
Downloads
How to Cite
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.